207 WEST 25TH ST, 9TH FLOOR, NEW YORK, NY
Announces 1-for-25 Reverse Stock Split
Stockholders Elect Lauren Chung as Class I Director at Special Meeting
Other Events
First Amendment to Asset Purchase Agreement with Bio Insights LLC
Annual Report to Security Holders
Announces Listing Transfer to The Nasdaq Capital Market
Receives Favorable Nasdaq Listing Determination
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
Notice of Late Filing for Quarterly Report
Q2
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload